Brief: Hillevax Reports First Quarter 2023 Financial Results And Highlights Recent Company Progress
12/05/2023 21:09
Hillevax Inc HLVX.O :
* HILLEVAX REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
HIGHLIGHTS RECENT COMPANY PROGRESS
* SEES TOPLINE SAFETY AND CLINICAL EFFICACY DATA FROM
NEST-IN1 IN
Q1 OF 2024
* AS OF MARCH 31, 2023, COMPANY HAD CASH AND CASH
EQUIVALENTS
TOTALING $260.5 MILLION
* Q1 EARNINGS PER SHARE VIEW $-0.95 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1dhccK
Further company coverage: HLVX.O
Recent news on HilleVax
See all newsBrief: XOMA Royalty Announces Closing Of Tender Offer For HilleVax
Brief: Hillevax Enters Into A Definitive Agreement To Be Acquired By Xoma Royalty For $1.95 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-US energy sector, Oshkosh, Meta
U.S. STOCKS ON THE MOVE-Zumiez, BTC Digital, WesBanco
U.S. STOCKS ON THE MOVE-Petco Health, Smith & Wesson, Victoria's Secret